Skip to content
Home/Companies/Healthcare/Wellium

Wellium

Healthcare·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Wellium?

Wellium is a French Healthcare company, currently owned by AdBio Partners since 2020.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorHealthcare

More from AFB Seed-Fund

Other portfolio companies in the same fund.

Alderaan Biotechnology
Active
BiotechFrance· 2020
ARTHEx Biotech
ARTHEx Biotech
Active
BiotechSpain· 2020
GAMUT Therapeutics
Exited 2021
BiotechFrance· 2020
to SparingVision
Kalsiom
Kalsiom
Active
BiotechFrance· 2020
Agomab Therapeutics
Agomab Therapeutics
Exited 2026
BiotechBelgium· 2019
to Nasdaq (IPO)
SparingVision
SparingVision
Active
BiotechFrance· 2019

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Wellium?

Wellium is currently owned by AdBio Partners, through AFB Seed-Fund, since 2020.

When did AdBio Partners acquire Wellium?

AdBio Partners acquired Wellium in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue